Clinical Trials Directory

Trials / Terminated

TerminatedNCT02826577

Effects of Pregnenolone on Perceived Social Isolation

Effects of Pregnenolone on Perceived Social Isolation: A Double-blind Randomized Electrical Neuroimaging Study

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
34 (actual)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Accepted

Summary

No studies to date have examined the effects of pregnenolone on hypervigilance for social threat in individuals with perceived social isolation (PSI). We therefore are conducting a double-blind randomized research study combining three validated behavioral paradigms on social threat attention, perception of others, and emotion regulation with high-density electrical neuroimaging to probe the neuro-circuitry of social threat processing in young adults high in perceived social isolation two hours after the oral administration of 175mg pregnenolone (N = 24), 400mg of pregnenolone (N = 24), or placebo (N = 24). Such research has the potential to yield important insights into the neurobehavioral mechanisms of pregnenolone on hypervigilance for social threat and perception of others--- a first key step toward the development of adjunctive pregnenolone therapy in individuals with PSI.

Conditions

Interventions

TypeNameDescription
DRUGPregnenolone 175mgSingle Dose 175mg
DRUGPregnenolone 400mgSingle Dose 400mg
DRUGPlaceboSingle Dose

Timeline

Start date
2017-05-01
Primary completion
2021-12-21
Completion
2022-12-21
First posted
2016-07-11
Last updated
2024-05-16
Results posted
2024-05-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02826577. Inclusion in this directory is not an endorsement.